- $573.52m
- $454.89m
- $418.63m
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million
MiMedx Group Inc expected to post a loss of 5 cents a share - Earnings Preview
MiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
MiMedx Q2 net sales up 13%, beat expectations
Brief: MiMedx Group Announces Strategic Collaboration With Vaporox, Inc.
MiMedx Group Inc reports results for the quarter ended March 31 - Earnings Summary
MiMedx Group Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: MiMedx Group Files Patent Infringement Lawsuit Against Surgenex
RCS - EW Healthcare Ptrs - EW Healthcare Partners’ Leadership Evolution
MiMedx Group Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: MiMedx Q3 Sales USD 84.057 Million Vs. IBES Estimate USD 82.7 Million